This study explores the potential of stem cell therapy as a treatment for strokes, a neurological disorder resulting from impaired blood perfusion to the brain. Despite the existing use of tissue plasminogen activator (tPA), its limitations underscore the necessity for novel therapy. Stem cell therapy emerges as a promising avenue.